Supplier-branded blend of GHK-Cu, BPC-157, and TB-500
Commonly listed as a 70mg vial (50mg GHK-Cu + 10mg BPC-157 + 10mg TB-500), though exact ratios vary by supplier.
This page is for educational and informational purposes only. PeptideSuppliers.org does not sell peptides, provide medical advice, or recommend human use.
GLOW is not a single peptide. It is a supplier-coined name for a pre-mixed blend that combines three separately studied compounds in one vial: GHK-Cu, BPC-157, and TB-500.
The most common published ratio is 50mg GHK-Cu, 10mg BPC-157, and 10mg TB-500 for a 70mg total blend, though suppliers can vary the exact milligram split, so the label on any given listing should always be checked directly.
Skin, collagen, and wound-healing research (from GHK-Cu) alongside tissue-repair and tendon/ligament research (from BPC-157 and TB-500).
Preclinical for all three ingredients individually; the combined blend itself has no dedicated trial record.
Use the linked literature searches for current papers and trial records on each component peptide.
Because GLOW is a named combination rather than a single molecule, the relevant research sits with its three ingredients individually: GHK-Cu's role in collagen and extracellular matrix biology, and BPC-157 and TB-500's roles in tissue-repair and angiogenesis models.
Each ingredient has its own preclinical literature, but the specific combined formula sold as "GLOW" has not itself been studied as a unit in published research.
GHK-Cu is a copper-binding tripeptide studied for roles in collagen synthesis, extracellular matrix remodeling, and antioxidant activity, which is why it anchors the "glow" positioning around skin-related research.
BPC-157 and TB-500 (thymosin beta-4) are both studied in tissue-repair and wound-healing models, including tendon, ligament, and gastrointestinal research for BPC-157, and angiogenesis and actin-binding research for TB-500.
Because the blend combines three independently studied peptides rather than testing the mixture itself, a reader should evaluate the documentation for each ingredient separately rather than treating "GLOW" as a single research-backed entity.
A trustworthy GLOW listing should spell out the exact milligram amount of each of the three ingredients, provide a batch-specific COA for the finished blend, and avoid implying the combination itself has been clinically tested.
Use these pages to compare naming, documentation access, and overall page clarity.
This listing is useful for checking naming, documentation access, and overall page clarity.
15% off with code PPL15Use related pages to compare nearby compounds and adjacent research categories.
Quick answers to the main questions that come up on this page.
GLOW is a supplier-branded name for a peptide blend that combines GHK-Cu, BPC-157, and TB-500 in one vial, most commonly formulated as 50mg GHK-Cu, 10mg BPC-157, and 10mg TB-500 (a 70mg total blend). It is not itself a single studied compound; it is a mixture of three separately studied peptides.
Each ingredient carries its own research base: GHK-Cu is linked to skin, collagen, and wound-healing research; BPC-157 and TB-500 are linked to tissue-repair and tendon/ligament research. There is little to no published literature testing the specific 50/10/10 combination itself.
Not necessarily. "GLOW" is a marketing name rather than a regulated term, so the exact milligram ratio of GHK-Cu, BPC-157, and TB-500 can differ between suppliers. Always check the specific label.
Not as a combined formula. The published research covers each ingredient individually rather than the specific pre-mixed blend sold under this name.
Look for a supplier page that lists the exact milligram breakdown of each ingredient, provides a batch-specific COA covering the finished blend (not just the individual raw peptides), and avoids treating the combination as if it had its own dedicated clinical evidence.